- Home
- JNVR vs PAVM Comparison
JNVR vs PAVM Comparison
Compare JNVR & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- PAVM
- Stock Information
- Founded
- JNVR 2018
- PAVM 2014
- Country
- JNVR United States
- PAVM United States
- Employees
- JNVR N/A
- PAVM N/A
- Industry
- JNVR Finance: Consumer Services
- PAVM Medical/Dental Instruments
- Sector
- JNVR Finance
- PAVM Health Care
- Exchange
- JNVR Nasdaq
- PAVM Nasdaq
- Market Cap
- JNVR 7.0M
- PAVM 8.0M
- IPO Year
- JNVR 2023
- PAVM 2016
- Fundamental
- Price
- JNVR $4.72
- PAVM $0.79
- Analyst Decision
- JNVR
- PAVM Strong Buy
- Analyst Count
- JNVR 0
- PAVM 1
- Target Price
- JNVR N/A
- PAVM $19.00
- AVG Volume (30 Days)
- JNVR 7.2K
- PAVM 248.8K
- Earning Date
- JNVR 03-27-2025
- PAVM 03-25-2025
- Dividend Yield
- JNVR N/A
- PAVM N/A
- EPS Growth
- JNVR N/A
- PAVM N/A
- EPS
- JNVR N/A
- PAVM 0.53
- Revenue
- JNVR $1,820,969.00
- PAVM $4,034,000.00
- Revenue This Year
- JNVR N/A
- PAVM $52.90
- Revenue Next Year
- JNVR N/A
- PAVM $248.84
- P/E Ratio
- JNVR N/A
- PAVM $1.50
- Revenue Growth
- JNVR N/A
- PAVM 166.27
- 52 Week Low
- JNVR $3.37
- PAVM $0.57
- 52 Week High
- JNVR $11.84
- PAVM $3.50
- Technical
- Relative Strength Index (RSI)
- JNVR 40.24
- PAVM 60.82
- Support Level
- JNVR $4.91
- PAVM $0.73
- Resistance Level
- JNVR $5.35
- PAVM $0.90
- Average True Range (ATR)
- JNVR 0.25
- PAVM 0.08
- MACD
- JNVR -0.08
- PAVM 0.02
- Stochastic Oscillator
- JNVR 15.30
- PAVM 65.02
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.